These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 27312615)

  • 1. MDG-1, an Ophiopogon polysaccharide, alleviates hyperlipidemia in mice based on metabolic profile of bile acids.
    Shi L; Wang J; Wang Y; Feng Y
    Carbohydr Polym; 2016 Oct; 150():74-81. PubMed ID: 27312615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MDG-1, an Ophiopogon polysaccharide, restrains process of non-alcoholic fatty liver disease via modulating the gut-liver axis.
    Wang X; Shi L; Wang X; Feng Y; Wang Y
    Int J Biol Macromol; 2019 Dec; 141():1013-1021. PubMed ID: 31491513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MDG-1, a Potential Regulator of PPARα and PPARγ, Ameliorates Dyslipidemia in Mice.
    Wang X; Shi L; Joyce S; Wang Y; Feng Y
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28885549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fecal metabonomic study of a polysaccharide, MDG-1 from Ophiopogon japonicus on diabetic mice based on gas chromatography/time-of-flight mass spectrometry (GC TOF/MS).
    Zhu Y; Cong W; Shen L; Wei H; Wang Y; Wang L; Ruan K; Wu F; Feng Y
    Mol Biosyst; 2014 Feb; 10(2):304-12. PubMed ID: 24292023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MDG-1, a polysaccharide from Ophiopogon japonicus, prevents high fat diet-induced obesity and increases energy expenditure in mice.
    Wang Y; Zhu Y; Ruan K; Wei H; Feng Y
    Carbohydr Polym; 2014 Dec; 114():183-189. PubMed ID: 25263880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MDG-1, an Ophiopogon polysaccharide, regulate gut microbiota in high-fat diet-induced obese C57BL/6 mice.
    Shi LL; Li Y; Wang Y; Feng Y
    Int J Biol Macromol; 2015 Nov; 81():576-83. PubMed ID: 26321425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MDG-1, a polysaccharide from Ophiopogon japonicus exerts hypoglycemic effects through the PI3K/Akt pathway in a diabetic KKAy mouse model.
    Wang LY; Wang Y; Xu DS; Ruan KF; Feng Y; Wang S
    J Ethnopharmacol; 2012 Aug; 143(1):347-54. PubMed ID: 22776833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of MDG-1, a polysaccharide from Ophiopogon japonicas, on diversity of lactobacillus in diet-induced obese mice].
    Shi LL; Wang Y; Feng Y
    Zhongguo Zhong Yao Za Zhi; 2015 Feb; 40(4):716-21. PubMed ID: 26137696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoglycemic effects of MDG-1, a polysaccharide derived from Ophiopogon japonicas, in the ob/ob mouse model of type 2 diabetes mellitus.
    Xu J; Wang Y; Xu DS; Ruan KF; Feng Y; Wang S
    Int J Biol Macromol; 2011 Nov; 49(4):657-62. PubMed ID: 21756932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feces and liver tissue metabonomics studies on the regulatory effect of aspirin eugenol eater in hyperlipidemic rats.
    Ma N; Liu X; Kong X; Li S; Jiao Z; Qin Z; Dong P; Yang Y; Li J
    Lipids Health Dis; 2017 Dec; 16(1):240. PubMed ID: 29228968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MDG, an Ophiopogon japonicus polysaccharide, inhibits non-alcoholic fatty liver disease by regulating the abundance of Akkermansia muciniphila.
    Zhang L; Wang Y; Wu F; Wang X; Feng Y; Wang Y
    Int J Biol Macromol; 2022 Jan; 196():23-34. PubMed ID: 34920070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ganoderic acid A from Ganoderma lucidum ameliorates lipid metabolism and alters gut microbiota composition in hyperlipidemic mice fed a high-fat diet.
    Guo WL; Guo JB; Liu BY; Lu JQ; Chen M; Liu B; Bai WD; Rao PF; Ni L; Lv XC
    Food Funct; 2020 Aug; 11(8):6818-6833. PubMed ID: 32686808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylophiopogonanone A, an Ophiopogon homoisoflavonoid, alleviates high-fat diet-induced hyperlipidemia: assessment of its potential mechanism.
    Li Z; Wu YY; Yu BX
    Braz J Med Biol Res; 2020; 53(3):e9201. PubMed ID: 32130294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of a farnesoid X receptor antagonist on hepatic lipid metabolism in primates.
    Amano Y; Shimada M; Miura S; Adachi R; Tozawa R
    Eur J Pharmacol; 2014 Jan; 723():108-15. PubMed ID: 24361308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alkaloids of dendrobium nobile lindl. Altered hepatic lipid homeostasis via regulation of bile acids.
    Huang S; Wu Q; Liu H; Ling H; He Y; Wang C; Wang Z; Lu Y; Lu Y
    J Ethnopharmacol; 2019 Sep; 241():111976. PubMed ID: 31132462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. UPLC/Q-TOF-MS/MS-based metabolomics revealed the lipid-lowering effect of Ilicis Rotundae Cortex on high-fat diet induced hyperlipidemia rats.
    Yang B; Xuan S; Ruan Q; Jiang S; Cui H; Zhu L; Luo X; Jin J; Zhao Z
    J Ethnopharmacol; 2020 Jun; 256():112784. PubMed ID: 32222573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rhizoma Coptidis alkaloids alleviate hyperlipidemia in B6 mice by modulating gut microbiota and bile acid pathways.
    He K; Hu Y; Ma H; Zou Z; Xiao Y; Yang Y; Feng M; Li X; Ye X
    Biochim Biophys Acta; 2016 Sep; 1862(9):1696-709. PubMed ID: 27287254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PL-S2, a homogeneous polysaccharide from Radix Puerariae lobatae, attenuates hyperlipidemia via farnesoid X receptor (FXR) pathway-modulated bile acid metabolism.
    Rao Y; Wen Q; Liu R; He M; Jiang Z; Qian K; Zhou C; Li J; Du H; Ouyang H; Feng Y; Zhu W
    Int J Biol Macromol; 2020 Dec; 165(Pt B):1694-1705. PubMed ID: 33058986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysimachia christinae polysaccharide attenuates diet-induced hyperlipidemia via modulating gut microbes-mediated FXR-FGF15 signaling pathway.
    Zhou YF; Nie J; Shi C; Zheng WW; Ning K; Kang J; Sun JX; Cong X; Xie Q; Xiang H
    Int J Biol Macromol; 2023 Sep; 248():125725. PubMed ID: 37419267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholesterol-lowering effects and potential mechanisms of different polar extracts from Cyclocarya paliurus leave in hyperlipidemic mice.
    Jiang C; Wang Q; Wei Y; Yao N; Wu Z; Ma Y; Lin Z; Zhao M; Che C; Yao X; Zhang J; Yin Z
    J Ethnopharmacol; 2015 Dec; 176():17-26. PubMed ID: 26477373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.